Taplitumomab paptox
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Mouse |
| Target | CD19 |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number |
|
| ChemSpider |
|
  (what is this?) | |
Taplitumomab paptox is a mouse monoclonal antibody designed for the treatment of cancer.[citation needed] The antibody itself, taplitumomab, is linked to the protein PAP, an antiviral from Phytolacca americana, a species of pokeweed.[1] This is reflected by the 'paptox' in the drug's name.
References[]
 | This monoclonal antibody–related article is a stub. You can help Wikipedia by . |
 | This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by . |
Categories:
- Drugs not assigned an ATC code
- Monoclonal antibodies for tumors
- Monoclonal antibody stubs
- Antineoplastic and immunomodulating drug stubs